BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36440797)

  • 1. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis.
    Thao V; Dholakia R; Moriarty JP; Borah BJ; Dwarkasing J; Meves A
    Int J Dermatol; 2023 Jan; 62(1):56-61. PubMed ID: 36440797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry.
    Herb JN; Ollila DW; Stitzenberg KB; Meyers MO
    Ann Surg Oncol; 2021 Jul; 28(7):3470-3478. PubMed ID: 33900501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
    Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
    Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study.
    Hieken TJ; Sadurní MB; Quattrocchi E; Kobic A; Sominidi-Damodaran S; Dwarkasing JT; Meerstein-Kessel L; Bridges AG; Meves A
    Int J Dermatol; 2022 Jul; 61(7):848-854. PubMed ID: 35100440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
    Knackstedt TJ
    J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity.
    Leong WL; Ghazarian DM; McCready DR
    J Surg Oncol; 2003 Mar; 82(3):143-6. PubMed ID: 12619055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost.
    Hu Y; Briggs A; Gennarelli RL; Bartlett EK; Ariyan CE; Coit DG; Brady MS
    Ann Surg Oncol; 2020 Dec; 27(13):5248-5256. PubMed ID: 32514805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of CP-GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study.
    Yousaf A; Tjien-Fooh FJ; Rentroia-Pacheco B; Quattrocchi E; Kobic A; Tempel D; Kolodney M; Meves A
    Int J Dermatol; 2021 Jul; 60(7):851-856. PubMed ID: 33914348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
    Aiken TJ; Stahl CC; Schwartz PB; Barrett J; Acher AW; Lemaster D; Leverson G; Weber S; Neuman H; Abbott DE
    J Surg Oncol; 2021 Jan; 123(1):104-109. PubMed ID: 32939750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
    Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
    Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications in the surgical treatment of pediatric melanoma.
    Palmer PE; Warneke CL; Hayes-Jordan AA; Herzog CE; Hughes DP; Lally KP; Austin MT
    J Pediatr Surg; 2013 Jun; 48(6):1249-53. PubMed ID: 23845614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.
    Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T;
    Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary.
    Johansson I; Tempel D; Dwarkasing JT; Rentroia-Pacheco B; Mattsson J; Ny L; Olofsson Bagge R
    Eur J Surg Oncol; 2022 Feb; 48(2):320-325. PubMed ID: 34794843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
    Mills JK; White I; Diggs B; Fortino J; Vetto JT
    Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Completion Lymphadenectomy on Quality of Life for Head and Neck Cutaneous Melanoma.
    Farlow JL; McLean SA; Peddireddy N; Bradford CR; Malloy KM; Stucken CL; VanKoevering KK; Spector ME; Rosko AJ
    Otolaryngol Head Neck Surg; 2022 Feb; 166(2):313-320. PubMed ID: 33874791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.